Angiogenesis, IL-1-dependent VEGF production, increased VEGFR |
Generation of Myeloid-derived Suppressor Cells (MDSC) |
Elevated IL-8 and chemokines, including monocyte chemotaxis (for MDSC) |
Migration of endothelial precursors into tumors |
Increased basic FGF, PDGF, IL-6 and other stromal growth factors |
Neutrophil accumulation in tumor |
Growth factor production (GM-CSF, FGF, IL-6, IL-1, chemokines) |
Thrombocytosis, platelet-derived IL-1α |
Induction of matrix metalloproteinases (MMP) for local spread |
Cyclooxygenase (increased PGE2) for immunosuppression |
Immunosuppression (increased PD-l ligand and CTLA-4) |
Low IL-1Ra circulating levels due to high uric acid levels |
Increased endothelial tissue factor for coagulopathy |
Increased ICAM-1, increased VCAM-1 for local and metastatic tumor spread |